Boots goes public: how British retail is relaunching its growth model | News Idea

Boots, one of the largest retailers in the United Kingdom, is preparing for an IPO after five years of stable sales growth of 6% per year. We examine why investors are paying attention to pharmaceutical retail and which business models can be scaled against this backdrop.

What happened

Boots, an iconic British pharmacy and retail chain, announced preparations for a public offering of shares. Over the past five years, the company has demonstrated stable sales growth of 6% annually — an indicator that is considered very convincing in a mature market. The pharmacy chain with more than a century of history is betting that investors will value the resilience of a business model combining pharmaceuticals, cosmetics, and everyday goods. The IPO is positioned as “bigger, bolder, more beautiful” — larger-scale, bolder, more beautiful. This is not just a marketing phrase: the company is indeed expanding its assortment, investing in digital channels, and updating the visual identity of its stores.

Why this is useful for business

For entrepreneurs and startup founders, the Boots story is a case of how a mature industry rethinks itself without radically breaking the model. The key lesson: stable growth of 6% per year is achievable without hype technologies — through improving customer experience, optimizing the assortment, and intelligently expanding into adjacent categories. Boots proves that pharmaceutical retail is not about cheap goods, but about trust and repeat purchases. The “pharmacy plus beauty retail” model generates repeat visits and high customer lifetime value. For startup founders, this is a signal: at the intersection of familiar industries, it is possible to build a resilient business with predictable revenue.

How to make money from this

Boots monetizes through several streams: sales of its own private labels (No7, Boots Botanics), partnerships with cosmetics and health brands, its own pharmacy services, and a growing digital direction — delivery, subscriptions for care products, telemedicine. The average check in the beauty segment is significantly higher than in a standard pharmacy, while purchase frequency is provided by everyday goods. The company also earns from rental space in its stores and from loyalty programs, collecting data on customer preferences for targeted offers.

Business ideas

1. A subscription service for health and beauty products. Assemble a basic set of products — vitamins, skincare cosmetics, sunscreens — and deliver it by subscription. Average check $35–$80 per month, with customer retention through personalization based on a questionnaire about skin type and lifestyle.

2. A mini-pharmacy in a dark store or kiosk format in business centers. Place an automated point with basic medicines, dietary supplements, first-aid products, and beauty products. Operating costs are lower than those of a traditional pharmacy, and the reach is office employees with regular demand.

3. A care recommendation platform with e-commerce integration. Create an AI bot that selects cosmetics and supplements based on a skin photo, lifestyle, and budget. Earn commissions from sales through partner stores — $2–$5 from each item sold.

4. A line of own-brand products for pharmacies and retailers. Develop a basic collection of skincare cosmetics or dietary supplements under your own brand. Work under the private label model: production costs $3–$8 per unit, retail price — $20–$45, and the margin reaches 70%.

5. A telemedicine service with prescription issuance and medicine delivery. Combine online consultations with medicine logistics. Subscription model for corporate clients: $15–$25 per employee per month, reach — companies that care about staff health.

Risks and limitations

Pharmaceutical retail is regulated more strictly than ordinary commerce. In most jurisdictions, licenses are required to sell medicines, and drug marketing is restricted. Competition from large chains and marketplaces is intensifying: Amazon, CVS, Walgreens are actively investing in digital channels. In addition, dependence on supply chains and currency fluctuations can affect the cost of goods. For a startup founder, launching in this segment requires legal preparation and substantial initial investment in warehousing and logistics.

7-day action plan

Day 1–2. Study the regulatory requirements for selling dietary supplements, cosmetics, and over-the-counter medicines in your target jurisdiction. Determine what license is needed and how much obtaining it costs.

Day 3. Analyze the assortment matrices of Boots, CVS, Walgreens, and three niche players. Identify categories with high margins and a low entry barrier.

Day 4. Compile a list of 10 potential private label suppliers in China, South Korea, or India. Request samples and price lists — focus on an MOQ from 500 units.

Day 5. Define the monetization model: subscription, one-off sale, commission, or hybrid. Calculate unit economics for one product — the goal is a margin of at least 50%.

Day 6. Assemble an MVP landing page or a simple online store. Connect a payment system and set up analytics — Google Analytics, Mixpanel, or an equivalent.

Day 7. Launch targeted ads on Instagram and Meta with a budget of $200–$300. Test three creatives, measure conversion cost and retention in the first week.

Original news: Financial Times Companies · See other news in the news section.